I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 23% ± 6% | |
| natural killer cell | 8 studies | 20% ± 5% | |
| epithelial cell | 7 studies | 30% ± 11% | |
| classical monocyte | 6 studies | 25% ± 11% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 22% ± 6% | |
| retinal cone cell | 5 studies | 24% ± 6% | |
| ciliated cell | 5 studies | 24% ± 7% | |
| macrophage | 5 studies | 19% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 17% ± 2% | |
| non-classical monocyte | 4 studies | 29% ± 12% | |
| retinal rod cell | 4 studies | 19% ± 1% | |
| cardiac muscle cell | 4 studies | 19% ± 3% | |
| basal cell | 4 studies | 25% ± 9% | |
| astrocyte | 4 studies | 22% ± 7% | |
| goblet cell | 4 studies | 25% ± 10% | |
| B cell | 3 studies | 18% ± 1% | |
| mature NK T cell | 3 studies | 18% ± 3% | |
| GABAergic neuron | 3 studies | 28% ± 6% | |
| glutamatergic neuron | 3 studies | 37% ± 9% | |
| monocyte | 3 studies | 18% ± 1% | |
| endothelial cell of lymphatic vessel | 3 studies | 21% ± 1% | |
| gamma-delta T cell | 3 studies | 24% ± 10% | |
| transit amplifying cell | 3 studies | 28% ± 15% | |
| abnormal cell | 3 studies | 20% ± 5% |
